Clear examples are anti-IL-6 compounds for patients with severe forms of COVID-19 (Fu et al., 2020; Zhang et al., 2020; Zhou et al., 2020) and hydroxychloroquine, widely used and highly questioned (Adhanom Ghebreyesus, 2020; Mehra et al., 2020). The gene discussed is IL6; the disease is COVID-19.